{"id":24891,"date":"2023-09-19T16:18:49","date_gmt":"2023-09-19T14:18:49","guid":{"rendered":"https:\/\/www.hollandbio.nl\/?p=24891"},"modified":"2023-09-19T16:18:49","modified_gmt":"2023-09-19T14:18:49","slug":"hoe-verbeteren-we-de-financiering-van-nederlandse-biotechbedrijven","status":"publish","type":"post","link":"https:\/\/www.hollandbio.nl\/en\/nieuws\/hoe-verbeteren-we-de-financiering-van-nederlandse-biotechbedrijven\/","title":{"rendered":"Hoe verbeteren we de financiering van Nederlandse biotechbedrijven?"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Wereldwijd verkeren techbedrijven in zwaar weer. Een opeenstapeling van ontwikkelingen zoals de oorlog in Oekra\u00efne, torenhoge inflatie en rente, een bear market op de beurs en het omvallen van de Silicon Valley Bank liggen daaraan ten grondslag. Voor biotech bedrijven is het niet anders, zo berichten onder andere <a href=\"https:\/\/www.nature.com\/articles\/s41587-023-01661-7\" target=\"_blank\" rel=\"noreferrer noopener\"><strong>Nature<\/strong><\/a>, <a href=\"https:\/\/www.biopharmadive.com\/news\/biotech-startups-venture-series-a-cliff-funding\/645883\/?utm_source=Sailthru&amp;utm_medium=email&amp;utm_campaign=Newsletter%20Weekly%20Roundup:%20BioPharma%20Dive:%20Daily%20Dive%2003-25-2023&amp;utm_term=BioPharma%20Dive%20Weekender\" target=\"_blank\" rel=\"noreferrer noopener\"><strong>Biopharmadive<\/strong><\/a> en <a href=\"https:\/\/www.fiercebiotech.com\/biotech\/2023-forecast-after-year-torrential-reductions-biotech-industry-yearns-brighter-days-are\" target=\"_blank\" rel=\"noreferrer noopener\"><strong>Fierce Biotech<\/strong><\/a>.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Omdat ook wij steeds meer berichten langs zien komen van bedrijven die in financi\u00eble moeilijkheden verkeren, willen we de krachten bundelen om het tij te keren. De eerste stap daarin is het in kaart brengen van het financieringslandschap voor Nederlandse biotech, om zo kansen, bedreigingen en veranderingen te identificeren. Een goede diagnose is immers essentieel voor de juiste aanpak. Heb je waardevolle inzichten of informatie over financiering in de biotechsector? Neem dan contact op met <strong><a href=\"mailto:max.vandenberg@hollandbio.nl\">hollandbio&#8217;s Ma<\/a>x<\/strong>. \u00a0<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Wereldwijd verkeren techbedrijven in zwaar weer. Een opeenstapeling van ontwikkelingen zoals de oorlog in Oekra\u00efne, torenhoge inflatie en rente, een bear market op de beurs en het omvallen van de Silicon Valley Bank liggen daaraan ten grondslag. Voor biotech bedrijven is het niet anders, zo berichten onder andere Nature, Biopharmadive en Fierce Biotech.&nbsp; Omdat ook [&hellip;]<\/p>\n","protected":false},"author":20,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[57,43],"tags":[],"class_list":["post-24891","post","type-post","status-publish","format-standard","hentry","category-ijzersterk-innovatieklimaat","category-innovatieklimaat"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Hoe verbeteren we de financiering van Nederlandse biotechbedrijven? - hollandbio<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.hollandbio.nl\/en\/nieuws\/hoe-verbeteren-we-de-financiering-van-nederlandse-biotechbedrijven\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Hoe verbeteren we de financiering van Nederlandse biotechbedrijven? - hollandbio\" \/>\n<meta property=\"og:description\" content=\"Wereldwijd verkeren techbedrijven in zwaar weer. Een opeenstapeling van ontwikkelingen zoals de oorlog in Oekra\u00efne, torenhoge inflatie en rente, een bear market op de beurs en het omvallen van de Silicon Valley Bank liggen daaraan ten grondslag. Voor biotech bedrijven is het niet anders, zo berichten onder andere Nature, Biopharmadive en Fierce Biotech.&nbsp; Omdat ook [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.hollandbio.nl\/en\/nieuws\/hoe-verbeteren-we-de-financiering-van-nederlandse-biotechbedrijven\/\" \/>\n<meta property=\"og:site_name\" content=\"hollandbio\" \/>\n<meta property=\"article:published_time\" content=\"2023-09-19T14:18:49+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2025\/01\/hb-opengraph_illu.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"675\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Dina Diek\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@hollandbio\" \/>\n<meta name=\"twitter:site\" content=\"@hollandbio\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Dina Diek\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/hoe-verbeteren-we-de-financiering-van-nederlandse-biotechbedrijven\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/hoe-verbeteren-we-de-financiering-van-nederlandse-biotechbedrijven\\\/\"},\"author\":{\"name\":\"Dina Diek\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#\\\/schema\\\/person\\\/eeee9ee4c951ec5f60fb13e463d9892b\"},\"headline\":\"Hoe verbeteren we de financiering van Nederlandse biotechbedrijven?\",\"datePublished\":\"2023-09-19T14:18:49+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/hoe-verbeteren-we-de-financiering-van-nederlandse-biotechbedrijven\\\/\"},\"wordCount\":142,\"publisher\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#organization\"},\"articleSection\":[\"IJzersterk innovatieklimaat\",\"Innovatieklimaat\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/hoe-verbeteren-we-de-financiering-van-nederlandse-biotechbedrijven\\\/\",\"url\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/hoe-verbeteren-we-de-financiering-van-nederlandse-biotechbedrijven\\\/\",\"name\":\"Hoe verbeteren we de financiering van Nederlandse biotechbedrijven? - hollandbio\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#website\"},\"datePublished\":\"2023-09-19T14:18:49+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/hoe-verbeteren-we-de-financiering-van-nederlandse-biotechbedrijven\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/hoe-verbeteren-we-de-financiering-van-nederlandse-biotechbedrijven\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/hoe-verbeteren-we-de-financiering-van-nederlandse-biotechbedrijven\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Hoe verbeteren we de financiering van Nederlandse biotechbedrijven?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/\",\"name\":\"hollandbio\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#organization\",\"name\":\"hollandbio\",\"url\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.hollandbio.nl\\\/wp-content\\\/uploads\\\/2023\\\/08\\\/HollandBIO_logo.svg\",\"contentUrl\":\"https:\\\/\\\/www.hollandbio.nl\\\/wp-content\\\/uploads\\\/2023\\\/08\\\/HollandBIO_logo.svg\",\"width\":218.664,\"height\":29.659,\"caption\":\"hollandbio\"},\"image\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/hollandbio\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/hollandbio\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#\\\/schema\\\/person\\\/eeee9ee4c951ec5f60fb13e463d9892b\",\"name\":\"Dina Diek\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Hoe verbeteren we de financiering van Nederlandse biotechbedrijven? - hollandbio","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.hollandbio.nl\/en\/nieuws\/hoe-verbeteren-we-de-financiering-van-nederlandse-biotechbedrijven\/","og_locale":"en_US","og_type":"article","og_title":"Hoe verbeteren we de financiering van Nederlandse biotechbedrijven? - hollandbio","og_description":"Wereldwijd verkeren techbedrijven in zwaar weer. Een opeenstapeling van ontwikkelingen zoals de oorlog in Oekra\u00efne, torenhoge inflatie en rente, een bear market op de beurs en het omvallen van de Silicon Valley Bank liggen daaraan ten grondslag. Voor biotech bedrijven is het niet anders, zo berichten onder andere Nature, Biopharmadive en Fierce Biotech.&nbsp; Omdat ook [&hellip;]","og_url":"https:\/\/www.hollandbio.nl\/en\/nieuws\/hoe-verbeteren-we-de-financiering-van-nederlandse-biotechbedrijven\/","og_site_name":"hollandbio","article_published_time":"2023-09-19T14:18:49+00:00","og_image":[{"width":1200,"height":675,"url":"https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2025\/01\/hb-opengraph_illu.png","type":"image\/png"}],"author":"Dina Diek","twitter_card":"summary_large_image","twitter_creator":"@hollandbio","twitter_site":"@hollandbio","twitter_misc":{"Written by":"Dina Diek","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/hoe-verbeteren-we-de-financiering-van-nederlandse-biotechbedrijven\/#article","isPartOf":{"@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/hoe-verbeteren-we-de-financiering-van-nederlandse-biotechbedrijven\/"},"author":{"name":"Dina Diek","@id":"https:\/\/www.hollandbio.nl\/en\/#\/schema\/person\/eeee9ee4c951ec5f60fb13e463d9892b"},"headline":"Hoe verbeteren we de financiering van Nederlandse biotechbedrijven?","datePublished":"2023-09-19T14:18:49+00:00","mainEntityOfPage":{"@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/hoe-verbeteren-we-de-financiering-van-nederlandse-biotechbedrijven\/"},"wordCount":142,"publisher":{"@id":"https:\/\/www.hollandbio.nl\/en\/#organization"},"articleSection":["IJzersterk innovatieklimaat","Innovatieklimaat"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/hoe-verbeteren-we-de-financiering-van-nederlandse-biotechbedrijven\/","url":"https:\/\/www.hollandbio.nl\/en\/nieuws\/hoe-verbeteren-we-de-financiering-van-nederlandse-biotechbedrijven\/","name":"Hoe verbeteren we de financiering van Nederlandse biotechbedrijven? - hollandbio","isPartOf":{"@id":"https:\/\/www.hollandbio.nl\/en\/#website"},"datePublished":"2023-09-19T14:18:49+00:00","breadcrumb":{"@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/hoe-verbeteren-we-de-financiering-van-nederlandse-biotechbedrijven\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.hollandbio.nl\/en\/nieuws\/hoe-verbeteren-we-de-financiering-van-nederlandse-biotechbedrijven\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/hoe-verbeteren-we-de-financiering-van-nederlandse-biotechbedrijven\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.hollandbio.nl\/en\/"},{"@type":"ListItem","position":2,"name":"Hoe verbeteren we de financiering van Nederlandse biotechbedrijven?"}]},{"@type":"WebSite","@id":"https:\/\/www.hollandbio.nl\/en\/#website","url":"https:\/\/www.hollandbio.nl\/en\/","name":"hollandbio","description":"","publisher":{"@id":"https:\/\/www.hollandbio.nl\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.hollandbio.nl\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.hollandbio.nl\/en\/#organization","name":"hollandbio","url":"https:\/\/www.hollandbio.nl\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.hollandbio.nl\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2023\/08\/HollandBIO_logo.svg","contentUrl":"https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2023\/08\/HollandBIO_logo.svg","width":218.664,"height":29.659,"caption":"hollandbio"},"image":{"@id":"https:\/\/www.hollandbio.nl\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/hollandbio","https:\/\/www.linkedin.com\/company\/hollandbio\/"]},{"@type":"Person","@id":"https:\/\/www.hollandbio.nl\/en\/#\/schema\/person\/eeee9ee4c951ec5f60fb13e463d9892b","name":"Dina Diek"}]}},"_links":{"self":[{"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/posts\/24891","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/users\/20"}],"replies":[{"embeddable":true,"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/comments?post=24891"}],"version-history":[{"count":0,"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/posts\/24891\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/media?parent=24891"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/categories?post=24891"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/tags?post=24891"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}